Stay updated with breaking news from Performance Enzymes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Opaleye Management Inc. lowered its position in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 957,500 shares of the biotechnology company’s stock after selling 197,500 shares during the quarter. Codexis makes up […]
StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Tuesday. Other equities research analysts also recently issued research reports about the company. HC Wainwright downgraded Codexis from a buy rating to a neutral rating in a report on Tuesday, […]
StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a hold rating to a sell rating in a research report report published on Monday morning. CDXS has been the topic of a number of other reports. Piper Sandler lowered their price target on Codexis from $21.00 to $14.00 and set an overweight rating on […]
HC Wainwright lowered shares of Codexis (NASDAQ:CDXS – Get Rating) from a buy rating to a neutral rating in a report issued on Tuesday morning, Marketbeat reports. HC Wainwright also issued estimates for Codexis’ FY2023 earnings at ($1.10) EPS, Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at ($0.27) EPS, Q3 2024 earnings at […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) – Research analysts at HC Wainwright dropped their FY2023 earnings per share (EPS) estimates for Codexis in a research report issued on Tuesday, May 9th. HC Wainwright analyst S. Ramakanth now expects that the biotechnology company will post earnings per share of ($1.10) for the year, down from their […]